Dechra Pharmaceuticals PLC financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
£186.84M £210.27M £232.47M £253.80M £304.37M £349.96M £369.37M £389.24M £124.33M £189.18M £193.57M £203.48M £247.56M £359.30M £407.10M £481.80M £515.10M £608.00M £681.80M £761.50M £0.00M
GM % Gross Margin %
13.61% 14.13% 14.31% 14.52% 17.61% 21.05% 21.83% 22.70% 57.19% 53.23% 55.64% 57.08% 55.95% 54.52% 55.88% 57.74% 56.61% 56.89% 56.44% 56.41% 0.00%
OM Operating Margin
4.62% 5.35% 5.30% 5.46% 5.31% 5.18% 5.38% 5.88% 11.83% 11.05% 13.21% 13.00% 13.21% 11.19% 11.08% 10.50% 11.40% 14.31% 14.05% 2.25% 0.00%
EPS Earnings Per Share
£0.14 £0.16 £0.21 £0.29 £0.34 £0.32 £0.39 £0.36 £0.40 £0.43 £0.64 £0.76 £0.90 £0.92 £1.08 £1.21 £0.95 £0.00
Div. Dividends
£0.05 £0.05 £0.06 £0.07 £0.08 £0.09 £0.11 £0.12 £0.12 £0.14 £0.15 £0.17 £0.18 £0.21 £0.26 £0.32 £0.34 £0.41 £0.45 £0.13 £0.00
PR % Payout Ratio %
0 0 42.86% 43.75% 38.10% 0 37.93% 35.29% 37.50% 35.90% 41.67% 42.50% 41.86% 32.81% 34.21% 35.56% 36.96% 37.96% 37.19% 13.68% 0
Sha. Shares
0m 50.98m 51.12m 51.92m 52.8m 65.49m 66.01m 66.25m 66.79m 87.07m 87.3m 87.86m 88.05m 93.01m 93.44m 102.53m 102.86m 108.14m 108.36m 113.76m 0m
OCF Operating Cash Flow
£8.71M £9.53M £9.49M £9.21M £8.56M £20.33M £17.32M £16.75M £19.24M £36.87M £11.47M £40.98M £43.58M £77.40M £64.00M £81.80M £106.40M £89.10M £122.90M £63.60M £0.00M
FCF Free Cash Flow
£8.14M £8.89M £8.17M £8.39M £7.87M £19.45M £16.08M £12.66M £10.85M £33.20M £5.48M £37.22M £36.07M £66.68M £51.40M £59.30M £57.20M £-45.70M £45.30M £33.30M £0.00M
FCFS Free Cash Flow Per Share
£0.16 £0.15 £0.16 £0.07 £0.11 £0.25 £0.22 £0.18 £0.14 £0.32 £0.05 £0.42 £0.40 £0.72 £0.53 £0.58 £0.55 £-0.42 £0.42 £0.29 £0.00